{"schema_version":"secwatch.filing_event.v1","accession":"0001193805-22-000504","form_type":"8-K","ticker":"IMUX","cik":"0001280776","company_name":"IMMUNIC, INC.","filed_at":"2022-03-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.767228+00:00","generated_at":"2026-06-26T22:16:55.805648+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Immunic appoints Glenn Whaley as CFO and extends Executive Chairman Duane Nash's term to Dec 2022","bullets":["Glenn Whaley appointed CFO effective March 10, 2022; received option grant for 40,000 shares (25% vest March 10, 2023, remainder monthly).","Duane Nash's Executive Chairman agreement extended to December 31, 2022; base salary $29,358/month.","Nash receives one-time option grant for 75,000 shares, vesting monthly from April 10, 2022.","Both option exercise prices set at closing price on board approval date."],"urls":{"canonical":"https://secwatch.observer/filing/0001193805-22-000504","json":"https://secwatch.observer/filing/0001193805-22-000504.json","markdown":"https://secwatch.observer/filing/0001193805-22-000504.md","text":"https://secwatch.observer/filing/0001193805-22-000504.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1280776/000119380522000504/0001193805-22-000504-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1280776/000119380522000504/e621458_8k-immunic.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T22:16:55.805648+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bde3b49450","claim":"Glenn Whaley was appointed as Chief Financial Officer at IMMUNIC, INC..","evidence_excerpt":"On March 10, 2022, Glenn Whaley was appointed Chief Financial Officer (\"CFO\") of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380522000504/0001193805-22-000504-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}